LFCR
Lifecore Biomedical, Inc.NASDAQHealthcare$3.84+0.00%ClosedMarket Cap: $143.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.48
P/S
1.04
EV/EBITDA
-130.91
DCF Value
$-10.31
FCF Yield
1.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
32.3%
Operating Margin
-3.0%
Net Margin
-23.0%
ROE
-182.1%
ROA
-14.6%
ROIC
-2.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $44.4M | 35.8% | $2.3M | $-8.0M | $-0.25 | — |
| Q1 2026 | $31.1M | 25.0% | $-3.1M | $-10.0M | $-0.29 | — |
| Q4 2025 | $36.4M | 38.4% | $5.3M | $-1.1M | $-0.06 | — |
| FY 2025 | $128.9M | 31.3% | $-17.2M | $-38.7M | $-1.27 | — |
| Q3 2025 | $35.2M | 28.0% | $-9.0M | $-14.8M | $-0.47 | — |
| Q2 2025 | $32.6M | 34.0% | $-2.0M | $-6.6M | $-0.25 | — |
| Q1 2025 | $24.7M | 21.8% | $-11.6M | $-16.2M | $-0.53 | — |
| Q4 2024 | $37.9M | 45.6% | $2.1M | $-7.1M | $-0.23 | — |
| FY 2024 | $128.3M | 32.6% | $-8.8M | $12.0M | $0.33 | — |
| Q3 2024 | $35.7M | 33.3% | $-895.0K | $15.6M | $0.43 | — |
| Q2 2024 | $30.1M | 33.0% | $-1.5M | $14.2M | $0.39 | — |
| Q1 2024 | $24.5M | 11.1% | $-8.6M | $-10.8M | $-0.35 | — |